Pharma Related News
New pathway for approval of medicines in the UK
A new pathway for the approval of medicines in the UK has opened, aiming to bring closer collaboration between authorities and bodies and helping...
Oxford University COVID-19 vaccine roll out begins
The first person in the UK has now received the Oxford University and AstraZeneca COVID-19 vaccine, which has begun its NHS roll out today.
The...
European Commission concludes Novavax talks for COVID-19 vaccine
The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine.
The European Commission and Novavax envisaged...
Clinical trials for another COVID-19 vaccine begin in UK
Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
Pritelivir Phase III clinical trials for HSV immunocompromised patients
The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV)...
AstraZeneca to test component of Russia’s Sputnik V vaccine
AstraZeneca will be testing a component of Russia’s Sputnik V COVID-19 vaccine in clinical trials of its own vaccine against the virus.
Following the preliminary...
Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients
For the first time, patients in Scotland with previously untreated Chronic Lymphocytic Leukaemia will be able to access chemotherapy-free treatment.
The Scottish Medicines Consortium has...
COVID-19 Oxford vaccine found safe and effective in Phase III trial
The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus.
The...
First ever patient to receive COVID-19 vaccination in the UK
Today marks a landmark moment for the United Kingdom as the first NHS patient has received the Pfizer/BioNTech COVID-19 vaccine.
The biggest vaccination campaign in...
Clinical trial investigates COVID-19 protection for health professionals
Healthcare professionals in the UK will be taking part in a clinical trial to test the efficacy of Carragelose nasal spray for COVID-19 protection.
To...
Dealing with antimicrobial resistance during COVID-19
To coincide with Antimicrobial Awareness Week 2020, a new report of case studies has been published that gives a platform to people living with...
Over 50s in UK to receive free flu vaccine
The UK Government has announced that citizens over 50 in the UK will be able to receive a free flu vaccine from 1 December...
Oxford COVID-19 vaccine shows promising results in older adults
Phase II of the Oxford vaccine trial has shown promising safety results in older adults, finding it provokes an immune response.
The early stage results,...
COVID-19 vaccine Phase III clinical trials to begin in UK
Phase III clinical trials for a COVID-19 vaccine are set to begin in the UK and will involve 6,000 volunteers from across the country.
Global...
Can cannabis provide an alternative to opioid painkillers in the UK?
The past few years have seen a rise in the use of opioids as pain killers, but these medicines are highly addictive. Medical cannabis...
Community pharmacies – ready to act as a vaccine gateway
Jan De Belie, Professional Affairs Advisor at the Pharmaceutical Group of the European Union (PGEU), spoke to Health Europa Quarterly about how community pharmacies...
Vaccination: the pathway for concrete citizens’ engagement
The involvement of civil society actors in discussions around vaccination is crucial. Cittadinanzattiva’s Mariano Votta and Daniela Quaggia outline their work in this area.
Vaccine...
UK medicines regulator joins ACSS consortium of regulators
The UK medicines regulator, Medicines and Healthcare products Regulatory Agency (MHRA) has now joined the Australia-Canada-Singapore-Switzerland (ACSS) Consortium.
The ACSS Consortium will now be known...
Cannabis and chronic pain in Australia
Painaustralia tells MCN Quarterly about the use of cannabis to treat chronic pain.
Despite making up around 60% to 70% of the customer base for...
Ketamine therapy insights from experts in the field
A Molecular Masterclass conference delved into the benefits, research, and policy surrounding ketamine therapy.
The masterclass explored ketamine at the intersection of clinical care, research,...
